| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 60763-601-13 | 60763-601 | HUMAN PRESCRIPTION DRUG | PURINETHOL | Mercaptopurine | TABLET | ORAL | 20220115 | N/A | NDA | NDA009053 | Stason Pharmaceuticals, Inc. | MERCAPTOPURINE | 50 mg/1 | 25 TABLET in 1 BOTTLE, PLASTIC (60763-601-13) |
| 69076-913-02 | 69076-913 | HUMAN PRESCRIPTION DRUG | Mercaptopurine | Mercaptopurine | TABLET | ORAL | 20161005 | N/A | NDA AUTHORIZED GENERIC | NDA009053 | Quinn Pharmaceuticals | MERCAPTOPURINE | 50 mg/1 | 25 TABLET in 1 BOTTLE, PLASTIC (69076-913-02) |
| 69076-913-25 | 69076-913 | HUMAN PRESCRIPTION DRUG | Mercaptopurine | Mercaptopurine | TABLET | ORAL | 20161005 | N/A | NDA AUTHORIZED GENERIC | NDA009053 | Quinn Pharmaceuticals | MERCAPTOPURINE | 50 mg/1 | 250 TABLET in 1 BOTTLE, PLASTIC (69076-913-25) |